156 225

Cited 0 times in

한국 소아 수모세포종의 다기관 치료 성적

DC FieldValueLanguage
dc.contributor.author유철주-
dc.date.accessioned2014-12-21T17:08:34Z-
dc.date.available2014-12-21T17:08:34Z-
dc.date.issued2007-
dc.identifier.issn2233-5250-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/97026-
dc.description.abstractPurpose: Medulloblastoma is the most common primary malignant brain tumor of childhood. In spite of improved multimodality approach, 30∼40% of children with medulloblastoma still suffer from recurrence. Furthermore, many survivors have significant long-term sequelae. This study was undertaken to investigate the current status of childhood medulloblastoma in Korea. Methods: Questionnaires were sent to the member hospitals of the Korean Society of Pediatric Neuro-Oncology. One hundred and sixty seven cases from 20 university hospitals were collected and analyzed. Results: The median age at diagnosis was 6.9 years and the male to female ratio was 1.9:1. Patients in average risk group were 77 (46%) and those in high risk group were 90 (54%). In average risk group, 1 patient was treated with operation only, 4 were treated with operation and radiotherapy, 70 were treated with operation, radiotherapy and chemotherapy, 2 were treated with various treatments. In high risk group, 4 patients were treated with operation and radiotherapy, 9 were treated with operation and chemotherapy, 58 were treated with operation, radiotherapy and chemotherapy, 16 were treated with high dose chemotherapy and autologous stem cell rescue, and 3 were treated with various treatments. Median follow up was at 30.8 months, and 3 year EFS was 65% for all patients. The 3 year EFS were 78% for patients in average risk group and 54% for patients in high risk group. Conclusion: Diverse treatment protocols have been applied for childhood medulloblastoma in Korea. This study inspired the necessity of nation-wide protocols and prospective multicenter studies for medulloblastoma in Korea.-
dc.description.statementOfResponsibilityopen-
dc.format.extent167~175-
dc.relation.isPartOfClinical Pediatric Hematology-Oncology (임상소아혈액종양)-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.title한국 소아 수모세포종의 다기관 치료 성적-
dc.title.alternativeOutcome of Multicenter Study for Korean Children with Medulloblastoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pediatrics (소아과학)-
dc.contributor.googleauthor박현진-
dc.contributor.googleauthor남병호-
dc.contributor.googleauthor황태주-
dc.contributor.googleauthor최중언-
dc.contributor.googleauthor최은진-
dc.contributor.googleauthor조빈-
dc.contributor.googleauthor조병규-
dc.contributor.googleauthor정혜림-
dc.contributor.googleauthor정대철-
dc.contributor.googleauthor정낙균-
dc.contributor.googleauthor임호준-
dc.contributor.googleauthor임도훈-
dc.contributor.googleauthor이준아-
dc.contributor.googleauthor이영호-
dc.contributor.googleauthor이순용-
dc.contributor.googleauthor이건수-
dc.contributor.googleauthor유철주-
dc.contributor.googleauthor유은선-
dc.contributor.googleauthor유경하-
dc.contributor.googleauthor유건희-
dc.contributor.googleauthor왕규창-
dc.contributor.googleauthor안효섭-
dc.contributor.googleauthor안승도-
dc.contributor.googleauthor신형진-
dc.contributor.googleauthor성기웅-
dc.contributor.googleauthor서창옥-
dc.contributor.googleauthor서종진-
dc.contributor.googleauthor백희조-
dc.contributor.googleauthor박지경-
dc.contributor.googleauthor박준은-
dc.contributor.googleauthor박상규-
dc.contributor.googleauthor박병규-
dc.contributor.googleauthor박경덕-
dc.contributor.googleauthor문형남-
dc.contributor.googleauthor나영신-
dc.contributor.googleauthor김흥식-
dc.contributor.googleauthor김학기-
dc.contributor.googleauthor김태형-
dc.contributor.googleauthor김지윤-
dc.contributor.googleauthor김일한-
dc.contributor.googleauthor김승기-
dc.contributor.googleauthor김동석-
dc.contributor.googleauthor국훈-
dc.contributor.googleauthor구홍회-
dc.contributor.googleauthor강형진-
dc.contributor.googleauthor하정옥-
dc.contributor.googleauthor신희영-
dc.contributor.googleauthor임현선-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02524-
dc.relation.journalcodeJ00606-
dc.contributor.alternativeNameLyu, Chuhl Joo-
dc.contributor.affiliatedAuthorLyu, Chuhl Joo-
dc.rights.accessRightsfree-
dc.citation.volume14-
dc.citation.number2-
dc.citation.startPage167-
dc.citation.endPage175-
dc.identifier.bibliographicCitationClinical Pediatric Hematology-Oncology (임상소아혈액종양), Vol.14(2) : 167-175, 2007-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아청소년과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.